Nov 2018

Nov 16, 2018 DEP® docetaxel and DEP® cabazitaxel outperform in human pancreatic cancer model

Oct 2018

Oct 26, 2018 Quarterly Cashflow Report

Oct 17, 2018 Starpharma Investor Presentation for Citi Conference

Sep 2018

Sep 05, 2018 DEP® irinotecan outperforms in pancreatic cancer model

Aug 2018

Aug 31, 2018 AstraZeneca’s DEP Bcl2/xL inhibitors show compelling efficacy and synergy in combination

Aug 22, 2018 Motley Fool ‘Extreme Opportunities’ Advisor Dr Anirban Mahanti covers Starpharma’s 2018 Financial Year Results

Aug 21, 2018 Annual report and full year financial results

Jul 2018

Jul 17, 2018 Quarterly Cashflow Report

Jul 16, 2018 Starpharma CEO Dr Jackie Fairley interviewed by Alan Kohler for The Constant Investor

Jul 09, 2018 VivaGel® BV NDA advances to next stage of FDA review

Jul 01, 2018 Starpharma CEO Dr Jackie Fairley interviewed by Alan Kohler on Talking Business

Jul 01, 2018 Starpharma CEO Jackie Fairley featured on Qantas’ inflight magazine Travel Insider